Shareholders' equity - Changes in share capital (Details)
€ / shares in Units, $ / shares in Units, $ in Millions |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1 Months Ended |
12 Months Ended |
|
|
Dec. 15, 2025
EUR (€)
€ / shares
shares
|
Dec. 11, 2025
EUR (€)
€ / shares
shares
|
Dec. 02, 2025
EUR (€)
shares
|
Nov. 18, 2025
EUR (€)
€ / shares
shares
|
Nov. 05, 2025
EUR (€)
€ / shares
shares
|
Nov. 04, 2025
EUR (€)
€ / shares
shares
|
Oct. 09, 2025
EUR (€)
€ / shares
shares
|
Sep. 01, 2025
EUR (€)
shares
|
May 07, 2025
EUR (€)
€ / shares
shares
|
Apr. 28, 2025
EUR (€)
€ / shares
shares
|
Dec. 19, 2024
EUR (€)
€ / shares
shares
|
Dec. 16, 2024
EUR (€)
€ / shares
shares
|
Oct. 17, 2024
EUR (€)
€ / shares
shares
|
Mar. 25, 2024
EUR (€)
€ / shares
shares
|
Dec. 08, 2023
EUR (€)
€ / shares
shares
|
Aug. 31, 2023
EUR (€)
€ / shares
shares
|
Aug. 30, 2023
EUR (€)
€ / shares
shares
|
Nov. 30, 2025
EUR (€)
€ / shares
shares
|
Nov. 30, 2025
USD ($)
$ / shares
shares
|
May 31, 2025
shares
|
Dec. 31, 2025
EUR (€)
€ / shares
shares
|
Dec. 31, 2024
EUR (€)
€ / shares
shares
|
Dec. 31, 2023
EUR (€)
€ / shares
shares
|
Dec. 31, 2022
EUR (€)
€ / shares
shares
|
| Disclosure of classes of share capital [line items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Shareholders' equity |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
€ (28,522,000)
|
€ (106,647,000)
|
€ (32,032,000)
|
€ 45,476,000
|
| Issue of equity |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
284,621,000
|
57,338,000
|
30,587,000
|
|
| Increase (decrease) through share-based payment transactions, equity |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
26,769,000
|
3,580,000
|
3,969,000
|
|
| Transaction costs |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
€ 17,134,000
|
9,605,000
|
2,511,000
|
|
| Number of shares outstanding | shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
193,236,978
|
|
|
|
| Nominal value | € / shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
€ 0.01
|
|
|
|
| Capital increase |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
€ 206,441,000
|
€ 57,338,000
|
30,589,000
|
|
| August 2023 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Disclosure of classes of share capital [line items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Nominal value | € / shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
€ 0.01
|
|
|
|
|
|
|
|
|
| Number of shares issued during the period | shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
9,618,638
|
|
|
|
|
|
|
|
|
| Capital increase |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
€ 30,600,000
|
|
|
|
|
|
|
|
|
| Tranche I, 2024 Financing arrangement in three tranches |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Disclosure of classes of share capital [line items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Number of warrants exercised during the period | shares |
|
|
|
|
|
|
|
|
|
1,000,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Shares issued during period upon exercise of warrants | shares |
|
|
|
|
|
|
|
|
|
1,000,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Proceeds from exercise of warrants |
|
|
|
|
|
|
|
|
|
€ 10,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Tranche I, 2024 Financing arrangement in three tranches | T1 BSA Warrants |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Disclosure of classes of share capital [line items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Shares issued during period upon exercise of warrants | shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
9,372,755
|
|
|
|
| Number of warrants exercised | shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
9,372,755
|
|
|
|
| Tranche I, 2024 Financing arrangement in three tranches | T1 BSA warrants and T1 bis BSA warrants |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Disclosure of classes of share capital [line items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Nominal value | € / shares |
|
|
|
|
|
€ 0.01
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Shares issued during period upon exercise of warrants | shares |
|
|
|
|
|
321,031
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Proceeds from exercise of warrants |
|
|
|
|
|
€ 3,210
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Tranche I, phase I, 2024 Financing arrangement in three tranches | T1 BSA Warrants |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Disclosure of classes of share capital [line items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Number of warrants exercised during the period | shares |
|
|
1,251,724
|
|
|
|
|
6,800,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Shares issued during period upon exercise of warrants | shares |
|
|
1,251,724
|
|
|
|
|
6,800,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Proceeds from exercise of warrants |
|
|
€ 12,517
|
|
|
|
|
€ 68,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Tranche I, phase I, 2024 Financing arrangement in three tranches | T1 New Share |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Disclosure of classes of share capital [line items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Number of shares issued during the period | shares |
|
|
|
|
|
|
|
|
|
|
|
|
34,600,507
|
|
|
|
|
|
|
|
|
34,600,507
|
|
|
| Price per share | € / shares |
|
|
|
|
|
|
|
|
|
|
|
|
€ 1.35
|
|
|
|
|
|
|
|
|
€ 1.35
|
|
|
| Tranche II, 2024 Financing arrangement in three tranches | T2 BSA Prefunded Warrants |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Disclosure of classes of share capital [line items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Nominal value | € / shares |
|
|
|
|
|
|
|
|
€ 0.01
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Share price, measurement input | € / shares |
|
|
|
|
|
|
|
|
€ 3.19
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Tranche II, 2024 Financing arrangement in three tranches | T2 New Share |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Disclosure of classes of share capital [line items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Issue of equity |
|
|
|
|
|
|
|
|
€ 400,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Transaction costs |
|
|
|
|
|
|
|
|
€ 7,500,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Nominal value | € / shares |
|
|
|
|
|
|
|
|
€ 0.01
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Number of shares issued during the period | shares |
|
|
|
|
|
|
|
|
42,488,883
|
|
|
|
42,488,883
|
|
|
|
|
|
|
42,488,883
|
|
|
|
|
| Price per share | € / shares |
|
|
|
|
|
|
|
|
€ 1.35
|
|
|
|
€ 1.35
|
|
|
|
|
|
|
|
|
|
|
|
| Capital increase |
|
|
|
|
|
|
|
|
€ 57,400,000
|
|
|
|
€ 57,400,000
|
|
|
|
|
|
|
|
|
|
|
|
| Share price, measurement input | € / shares |
|
|
|
|
|
|
|
|
€ 3.19
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Fair value of shares issued |
|
|
|
|
|
|
|
|
€ 135,500,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Upsized underwritten public offering including underwriters' options, at the market program | ADS |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Disclosure of classes of share capital [line items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Transaction costs |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
€ 9,600,000
|
|
|
|
|
|
|
| Nominal value | € / shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
€ 0.01
|
|
|
|
|
|
|
| Number of shares issued during the period | shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
44,805,193
|
44,805,193
|
|
|
|
|
|
| Price per share | (per share) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
€ 3.33
|
$ 3.85
|
|
|
|
|
|
| Capital increase |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
€ 149,000,000
|
$ 172.5
|
|
|
|
|
|
| Number of shares represented by one depositary receipt |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1
|
|
|
|
|
|
|
| AGA 2024-1, AGA- 2024-2 and AGA 2024-3 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Disclosure of classes of share capital [line items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Nominal value | € / shares |
€ 0.01
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Number of shares issued during the period | shares |
907,756
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Share capital |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Disclosure of classes of share capital [line items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Shareholders' equity |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
€ 1,932,370
|
€ 956,624
|
521,158
|
€ 421,341
|
| Issue of equity |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
967,000
|
425,000
|
96,000
|
|
| Increase (decrease) through exercise of warrants, equity |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
€ 9,000
|
€ 11,000
|
€ 4,000
|
|
| Number of shares outstanding | shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
193,236,978
|
95,662,391
|
52,115,807
|
42,134,169
|
| Nominal value | € / shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
€ 0.01
|
€ 0.01
|
€ 0.01
|
€ 0.01
|
| Share capital | August 2023 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Disclosure of classes of share capital [line items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Issue of equity |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
€ 96,186
|
|
|
|
|
|
|
|
| Number of shares | shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
9,618,638
|
|
|
|
|
|
|
|
| Nominal value | € / shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
€ 0.01
|
|
|
|
|
|
|
|
| Share capital | Tranche I, 2024 Financing arrangement in three tranches |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Disclosure of classes of share capital [line items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Increase (decrease) through exercise of warrants, equity |
|
|
|
|
€ 3,210
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Number of shares | shares |
|
|
|
|
321,031
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Nominal value | € / shares |
|
|
|
|
€ 0.01
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Share capital | Tranche I, phase I, 2024 Financing arrangement in three tranches |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Disclosure of classes of share capital [line items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Issue of equity |
|
|
|
|
|
|
|
|
|
|
|
|
€ 346,005
|
|
|
|
|
|
|
|
|
|
|
|
| Increase (decrease) through exercise of warrants, equity |
|
€ 12,517
|
|
|
|
|
€ 68,000
|
|
|
€ 10,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Number of shares | shares |
|
1,251,724
|
|
|
|
|
6,800,000
|
|
|
1,000,000
|
|
|
34,600,507
|
|
|
|
|
|
|
|
|
|
|
|
| Nominal value | € / shares |
|
€ 0.01
|
|
|
|
|
€ 0.01
|
|
|
€ 0.01
|
|
|
€ 0.01
|
|
|
|
|
|
|
|
|
|
|
|
| Share capital | Tranche I, phase II, 2024 Financing arrangement in three tranches |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Disclosure of classes of share capital [line items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Issue of equity |
|
|
|
|
|
|
|
|
|
|
€ 78,721
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Number of shares | shares |
|
|
|
|
|
|
|
|
|
|
7,872,064
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Nominal value | € / shares |
|
|
|
|
|
|
|
|
|
|
€ 0.01
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Share capital | Tranche II, 2024 Financing arrangement in three tranches |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Disclosure of classes of share capital [line items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Issue of equity |
|
|
|
|
|
|
|
|
€ 424,889
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Number of shares | shares |
|
|
|
|
|
|
|
|
42,488,883
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Nominal value | € / shares |
|
|
|
|
|
|
|
|
€ 0.01
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Share capital | Upsized underwritten public offering including underwriters' options, at the market program | ADS |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Disclosure of classes of share capital [line items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Issue of equity |
|
|
|
€ 448,052
|
|
|
|
|
|
|
|
|
|
|
|
|
|
€ 400,000
|
|
|
|
|
|
|
| Number of shares | shares |
|
|
|
44,805,193
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Nominal value | € / shares |
|
|
|
€ 0.01
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Share capital | Bonus shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Disclosure of classes of share capital [line items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Increase (decrease) through share-based payment transactions, equity |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
€ 3,630
|
|
|
|
|
|
|
|
|
|
| Number of shares | shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
363,000
|
|
|
|
|
|
|
|
|
|
| Nominal value | € / shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
€ 0.01
|
|
|
|
|
|
|
|
|
|
| Share capital | AGA 2021 & AGA 2021 BIS |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Disclosure of classes of share capital [line items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Increase (decrease) through share-based payment transactions, equity |
|
|
|
|
|
|
|
|
|
|
|
|
|
€ 3,614
|
|
|
|
|
|
|
|
|
|
|
| Number of shares | shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
361,381
|
|
|
|
|
|
|
|
|
|
|
| Nominal value | € / shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
€ 0.01
|
|
|
|
|
|
|
|
|
|
|
| Share capital | AGA 2023-2 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Disclosure of classes of share capital [line items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Increase (decrease) through share-based payment transactions, equity |
|
|
|
|
|
|
|
|
|
|
|
€ 7,126
|
|
|
|
|
|
|
|
|
|
|
|
|
| Number of shares | shares |
|
|
|
|
|
|
|
|
|
|
|
712,632
|
|
|
|
|
|
|
|
|
|
|
|
|
| Nominal value | € / shares |
|
|
|
|
|
|
|
|
|
|
|
€ 0.01
|
|
|
|
|
|
|
|
|
|
|
|
|
| Share capital | AGA 2024-1, AGA- 2024-2 and AGA 2024-3 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Disclosure of classes of share capital [line items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Increase (decrease) through share-based payment transactions, equity |
€ 9,078
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Number of shares | shares |
907,756
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Nominal value | € / shares |
€ 0.01
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Premiums related to share capital |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Disclosure of classes of share capital [line items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Shareholders' equity |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
€ 528,230,262
|
€ 249,159,597
|
€ 201,862,263
|
€ 173,885,665
|
| Issue of equity |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
296,214,000
|
56,913,000
|
30,491,000
|
|
| Increase (decrease) through exercise of warrants, equity |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(9,000)
|
(11,000)
|
(4,000)
|
|
| Transaction costs |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
€ 17,134,000
|
€ 9,605,000
|
€ 2,511,000
|
|
| Premiums related to share capital | August 2023 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Disclosure of classes of share capital [line items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Issue of equity |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
€ 30,491,082
|
|
|
|
|
|
|
|
| Transaction costs |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
€ 2,510,855
|
|
|
|
|
|
|
|
| Premiums related to share capital | Tranche I, 2024 Financing arrangement in three tranches |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Disclosure of classes of share capital [line items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Increase (decrease) through exercise of warrants, equity |
|
|
|
|
€ 430,182
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Premiums related to share capital | Tranche I, phase I, 2024 Financing arrangement in three tranches |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Disclosure of classes of share capital [line items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Issue of equity |
|
|
|
|
|
|
|
|
|
|
|
|
€ 38,422,366
|
|
|
|
|
|
|
|
|
|
|
|
| Increase (decrease) through exercise of warrants, equity |
|
€ 1,677,310
|
|
|
|
|
€ 9,112,000
|
|
|
€ 1,340,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Premiums related to share capital | Tranche I, phase II, 2024 Financing arrangement in three tranches |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Disclosure of classes of share capital [line items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Issue of equity |
|
|
|
|
|
|
|
|
|
|
€ 8,885,708
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Premiums related to share capital | Tranche II, 2024 Financing arrangement in three tranches |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Disclosure of classes of share capital [line items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Issue of equity |
|
|
|
|
|
|
|
|
€ 127,595,233
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Premiums related to share capital | Upsized underwritten public offering including underwriters' options, at the market program | ADS |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Disclosure of classes of share capital [line items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Issue of equity |
|
|
|
€ 138,925,018
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Premiums related to share capital | Bonus shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Disclosure of classes of share capital [line items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Increase (decrease) through share-based payment transactions, equity |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
€ (3,630)
|
|
|
|
|
|
|
|
|
|
| Premiums related to share capital | AGA 2021 & AGA 2021 BIS |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Disclosure of classes of share capital [line items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Increase (decrease) through share-based payment transactions, equity |
|
|
|
|
|
|
|
|
|
|
|
|
|
€ (3,614)
|
|
|
|
|
|
|
|
|
|
|
| Premiums related to share capital | AGA 2023-2 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Disclosure of classes of share capital [line items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Increase (decrease) through share-based payment transactions, equity |
|
|
|
|
|
|
|
|
|
|
|
€ (7,126)
|
|
|
|
|
|
|
|
|
|
|
|
|
| Premiums related to share capital | AGA 2024-1, AGA- 2024-2 and AGA 2024-3 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Disclosure of classes of share capital [line items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Increase (decrease) through share-based payment transactions, equity |
€ (9,078)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|